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ABSTRACT 
 
 
Background: Implant therapy has been the gold standard in the past decade when it comes 
to replacing partially or complete edentulous oral cavities. Patients favor this line of 
treatment since it does mimic their natural teeth in esthetic, function and phonetics. 
Unfortunately, some initially integrated implants end up diagnosed with peri-implantitis, 
which threatens the longevity of those implants in their respective alveolar bone. Several 
methods have been discussed aiming to either salvage the diseased implant or prolong the 
life of it in patients’ oral cavities. In this protocol we studied the efficacy of one of the 
suggested protocols that has been used frequently in periodontal practices aiming to 
decontaminate the surface of previously diseased implants. 
 
Materials and methods: This study looked at the efficacy through two analyses, a 
descriptive and a quantitative. In the descriptive, several peri-implantitis diagnosed 
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implants were collected and distributed over 4 groups: Test, Negative Control, Positive 
control and compared to pristine implants. Osteoprogenitor cells were prepared in-vitro 
and seeded over these implants after applying the protocol on Test group only. The 
quantitative analysis used the EDX analysis to study the percentages of Titanium and 
Oxygen on contaminated implants before and after applying the protocol on. Deposits 
removal was tested as well to ensure efficacy of decontamination protocol. 
 
Results: Descriptive analysis showed that osteoprogenitor cells had higher attachment and 
proliferation on implants that followed the decontamination protocol vs. other groups. 
Quantitative analysis showed statistically significant higher titanium percentages after 
decontamination. Oxygen levels were higher as well but not statistically significant. 
Deposits were statistically significant in removal after decontamination protocol. 
 
Conclusion: Decontamination of previously diseased implants following the mentioned 
protocol has efficiently increased the chances of re-establishment of osseointegration in 
previously contaminated implants. 
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1 Introduction and background 
 
 
1.1 Dental Implant therapy: 
 
According to the World Health Organization (WHO), by the year 2020, 37.9 million people 
in the U.S. will suffer from one form or another of edentulism 1, either partial or full 
edentulism. Dental implant therapies are considered to be the gold standard in modern 
dentistry in terms of replacing missing teeth 2. Advance in the research and technology of 
dental implants has made the replacement of missing teeth with endosseous implants the 
standard care and an implant supported prosthesis as the first choice for treatment and long 
lasting rehabilitation 3.  The other option available to edentulous patients is dentures, 
whether fixed or removable, neither of which is as favorable as implants 4. The possibility 
of restoring missing teeth with fixed restorations supported by dental implants is the 
treatment of choice offered by the majority of clinicians 5. 
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1.2 Titanium in Dental Implants: 
 
Titanium was selected as a material of choice because of its biocompatibility. It has an 
excellent resistance to corrosion under normal conditions. It has the ability to inherent thin 
oxide layer on the surface that protects the bulk of the material from environment and any 
further erosion, along with its biological inactivity, since its presence as a metal, does not 
influence the tissues surrounding it 6-7. Furthermore, compared to other materials, titanium 
has superior mechanical properties as well being light in weight, which makes it favorable 
for bone implantation 8. The passive oxide layer mimics the ceramic nature of bone, and 
that is the reason why titanium is considered to have a good biologic performance as a 
dental implant 9. 
 
1.3 Titanium properties and cellular adhesion: 
 
Wettability of implant surface is related to surface energy of implant, which will determine 
the cellular attachment on its surface. Unfortunately, less known of the intrinsic wettability 
of bone and how to best mimic it’s property. Thus, surface wettability is not a focus of 
most surface characterizations of our interest 10, 11. 
Hydrophilic surfaces on the other hand, have been found in several studies to enhance 
cellular adhesion, proliferation, differentiation and bone mineralization compared to 
hydrophobic surfaces 12. Generally, hydrophilicity can influence the bonding strength and 
the total amount of proteins bound to a surface 13 
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1.4 Effect of hydrophilicity: 
 
Hydrophilic surface is less prone to hydrocarbon contamination when compared to 
hydrophobic surfaces 14. Since hydrophilic surfaces remain clean in comparison to 
hydrophilic surfaces, it maintains higher surface energy and good wettability, which allows 
the formation of strong, interface with bone 15. This increase in wettability has proven to 
enhance osteoblast differentiation and local factor production 16. 
Hydrophilic surfaces have another effect on the adsorption of various biological mediators, 
which will subsequently impact the healing cascade that will lead to tissue integration 17. 
A lot of work has been done on hard tissues cells such as osteoblasts showing the effect of 
hydrophilicity on its attachment, spreading, proliferation and differentiation 18. 
In a clinically proven study, combination of micro-roughness and super-hydrophilicity, can 
enhance osseointegration during the early phases of healing in a 6-week human submerged 
implants 19. 
 
  4 
1.5 Approaches for hydrophilization: 
 
1.5.1 Neutralization after acid Etching 
 
Which should occur in contaminant-free environment and implant is immediately exposed 
to neutral saline solution instead of air. Scharnweber et al. showed that hydrophilicity 
results are not sustained after acid-etching titanium surface if left in dry air or methanol 20. 
 
1.5.2 Radio frequency glow discharge (RFGD) 
 
It is an effective method to clean and sterilize inorganic surfaces along with elevating them 
to high-energy state correlated with better cellular adhesion due to reduction of 
contaminants 21. 
 
1.5.3 Atmospheric pressure plasma 
 
Another method of cleaning and hydrophilizing titanium surfaces 22. It helped in reducing 
contact angle on implant surface and supported spreading of osteoblastic cells. 
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1.6 Osseointegration: 
 
The Osseointegration process provides a sturdy connection between the bone and the grade 
IV titanium by in growth of osteoblasts 23-25. Implant stability relies primarily on 
osseointegration and is considered a prerequisite for implant loading and long-term clinical 
success of endosseous dental implants. The alternative would be fibrous encapsulation of 
dental implant, called fibrointegration, which results in mobility of the implant after 
loading 26. Osseointegration is defined as a direct structural and functional connection 
between ordered living bone and the surface of a load-bearing implant 27. It proceeds 
through 3 phases: 1) osseoinduction; 2) new bone formation; and 3) bone remodeling. 
Osseointegration requires a precise fitting into the bone and primary stability along with a 
bioactive surface that would attract bone formation around a bio-inactive material such as 
titanium 28. Albrektsson and colleagues established early criteria for the evaluation of 
successful implant. These measurements focused on the biological integration and 
mechanical stability of the dental implants 27. Numerous other studies have reported a 
general success rate of more than 90% for dental implant treatments 29-31. Implant success 
criteria have been modified to reflect esthetic considerations and soft tissue management 
after implant placement. Other research has focused on different structures and surface 
treatments. As a result, this has led to an increasing utilization of oral implants by dental 
practitioners 32-34.  
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1.7 Bone Biology: 
 
Bone is a specialized connective tissue that serves several functions including mechanical 
support, protection of major organs and acts to store minerals and growth factors.  Bone 
also has a metabolic function. It is imperative to understand the processes involved in bone 
formation, growth and remodeling under normal physiological conditions and alterations 
of these processes in pathology to be able to develop and improve therapeutic approaches 
to different medical conditions. 
There are three different mature cell types found in bone. Osteoblasts are bone-forming 
cells that develop from multi-potent stem cells, which can differentiate into different 
mesenchymal phenotypes, i.e. cartilage, bone, fat and muscle 35. These cells are located on 
the surface of bone and are responsible for bone matrix production and its mineralization. 
Osteocytes are osteoblasts that are entrapped in lacunae in bone matrix after its 
mineralization. These cells have processes that reach out to communicate with osteoblasts 
and other osteocytes. Their functions include matrix maintenance, calcium homeostasis 
and as mechano-sensory receptors which help regulate bone responses to stress and 
mechanical load. Last are osteoclasts, which are bone resorbing cells. They are derived 
from the monocyte/ macrophage linage, which differentiate into osteoclasts and fuse to 
make multinucleated giant cells 36. Osteoblasts synthesize and release factors that stimulate 
osteoclast formation and function 36. 
Formation of bone during embryonic development occurs in two distinct ways, 
intramembranous and endochondrial ossification. Intramembranous ossification occurs 
mainly in the flat bones of the face and cranium. In this type of bone formation a sheet of 
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highly vascularized mesenchyme differentiates into osteoblasts, which in turn synthesize 
and deposit bone matrix. This matrix later mineralizes to form immature woven bone that 
is eventually replaced by mature lamellar bone. Endochondrial ossification on the other 
hand occurs in the long bones of the axial and appendicular skeleton. In this process, 
mesenchymal cells initially differentiate into chondrocytes, which make up a cartilaginous 
model that is later on resorbed and replaced by bone. However, these two processes are not 
totally anatomically confined, parts of long bone are developed by intramembranous 
ossification and some areas of facial bones are developed by endochondrial process. Also, 
the steps involved in osteoblast differentiation leading to bone matrix deposition and 
mineralization are essentially the same in both intramembranous and endochondrial 
ossification 37.  
Bone is very dynamic with a remarkable regenerative potential that allows it to mold, 
reshape and repair itself in response to changing physical demands or following injury 38. 
This process is known as bone remodeling, and in addition to being an adaptive process, 
remodeling also serves a function of maintaining calcium homeostasis. Bone remodeling 
involves three major phases:  beginning with bone resorption by osteoclasts (bone 
resorbing cells), followed by a reversal phase in which osteoclasts stop removing bone and 
osteoblasts fill the defect and finally bone formation by osteoblasts 39. This process is 
highly controlled by both local and systemic growth factors. Systemic factors and 
hormones also play a role in regulating bone remodeling by modulating the production of 
growth factors and cytokines from bone cells and their release from bone matrix 40. 
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1.8 Bone remodeling: 
Bone remodeling, a complex process by which old bone is continuously replaced by new 
tissue, requires interaction between different cell phenotypes and is regulated by a variety 
of biochemical and mechanical factors allowing the maintenance of the shape, quality, and 
size of the skeleton 41. This process is performed by clusters of bone-resorbing osteoclasts 
and bone-forming osteoblasts arranged within temporary anatomical structures known as 
“basic multicellular units” (BMUs). This unique structures and arrangement of cells within 
the BMU is critical to bone remodeling, ensuring coordination of the sequential phases of 
this process: activation, resorption, reversal, formation, and termination 42.  In a remodeling 
cycle an active BMU osteoclasts act as the leading cells starting with bone resorption 
followed by reversal cells, of unclear phenotype, which consequently lay over the newly 
exposed bone surface. These cells presumably prepare the surface for new osteoblasts to 
begin bone formation and provide signals for osteoblast differentiation and migration in a 
reversal phase. Osteoblasts in the formation phase occupy the last part of the BMU by 
secreting and depositing un-mineralized bone matrix known as osteoid and help in 
monitoring its formation and mineralization into mature lamellar bone 42.  
When this phase is complete, the surface is covered with flattened lining cells and a 
prolonged resting period begins until a new remodeling cycle is initiated. The stages of the 
remodeling cycle have different lengths. In humans, resorption continues for about 4 or 5 
weeks, while formation can continue for 4 months until the new bone structural unit is 
completely created 36. A number of stimuli affect bone turnover, including hormones, 
cytokines, and mechanical stimuli. All of these factors affect the amount and quality of the 
tissue produced. Many of these processes have implications for bone health, disease, and 
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the feasibility of living in weightless environments 43. 
1.9 Bone remodeling after implant placement: 
 
Bone changes were reported after implant placement in three phases: healing, remodeling, 
and equilibrium. The remodeling phase is launched confronting the altered pattern of force 
transmission to the bone tissue. To withstand the applied functional load, continuous 
remodeling is conducted to reach a “steady state.” Mechanical stimulus is the primary bone 
modifier influenced by other in situ variables as hormonal, metabolic, genetic factors 44 In 
a patient with a dental implant, bone metabolism is challenged by a foreign body (non-
self/not part of the body), which induces strains and stresses on the surrounding bone 
during functional loading. This is indeed very different from a tooth (self/part of the body), 
which is part of the genetically determined and highly specialized dent-gingival complex 
that mediates the tooth attachment to the alveolar bone. An understanding of the 
fundamental difference between implants and teeth is of utmost importance when 
considering the related tissue responses 45-47. Araujo and Lindhe 48 used histologic means 
to determine the dimensional alterations that occurred in the bone following the placement 
of implants in fresh extraction sockets in the Beagle dog. Buccal and lingual full‐ thickness 
flaps were elevated in both quadrants of the mandible. The distal roots of the third and 
fourth premolars were removed. In the right jaw quadrants, implants (Straumann implants) 
with a rough surface were placed in the sockets so that the marginal border of the rough 
surface was below the buccal and lingual bone margin. In the left jaws, the sockets were 
left without implantation. After 3 months, the soft tissue at the experimental sites in the 
right and left jaw quadrants appeared to be properly healed. The histologic section showed 
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the newly formed bone covers the entrance of the socket. The lamellar bone of the buccal 
cortical plate is located about 2.2 mm apical to its lingual counterpart.  The marginal 
termination of the buccal bone plate is located about 2.4 mm apical to the lingual crest. The 
placement of an implant in the fresh extraction socket doesn’t preserve the cortical plate 
level before the extraction. After 3 months of healing the amount of reduction of the height 
of the buccal bone wall (in comparison to the lingual bone alteration) was similar at the 
implant sites and the edentulous sites. At 3 months, the vertical discrepancy between the 
buccal and lingual bone margins was >2 mm in both categories of sites. In human studies  
1.10 Osteoblast formation, ECM maturation and differentiation: 
 
 
Osteoblasts originate from mesenchymal cells. They are responsible for bone matrix 
deposition in both intramembranous and endochondrial bone formation 49. Osteoblast 
differentiation is a highly complicated process that has yet to be fully understood 50. The 
ability to isolate osteoblasts and culture them led to great discoveries in the field of 
osteoblast differentiation, bone matrix production, and mineralization 51. The processes 
that are involved in these events are precise, coordinated and tightly controlled by both 
local and systemic regulators. It has been shown by several carefully conducted studies of 
osteoblast development that the expression pattern of molecular markers at each phase of 
in vitro osteoblast development correlates with the actual differentiation events in vivo 52. 
Through these studies it was found that osteoblast differentiation involves three major 
stages: proliferation, ECM maturation and mineralization. Each of these stages is 
controlled by growth factors and is characterized by expression of different sets of genes. 
The first stage of differentiation starts with an increase in the proliferation of osteoblasts 
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forming a monolayer sheet of cells, this proliferation is accompanied by an increase in 
extracellular matrix production, comprising mainly type I collagen. Continuing cell 
division leads to nodule development which later becomes sites of mineral deposition 53. 
The proliferative stage of osteoblast differentiation is characterized by an early elevated 
expression of genes involved in cell cycle and cell growth (e.g. histones, c-myc, and c-fos), 
followed by expression of genes associated with cell adhesion proteins (e.g.; fibronectin) 
and extracellular matrix production (e.g.; collagen I)53. 
Matrix maturation is the following stage. It is characterized by an increased levels of 
enzymes involved in matrix maturation and organization (e.g. Lysyl Oxidase). These 
enzymes create an environment that is suitable for mineral deposition by modifying the 
extracellular matrix (ECM). ECM modifications include organization of the collagenous 
matrix and deposition of non-collagenous proteins, matrix-GLA proteins, proteoglycans 
and growth factors that constitute the organic components of bone ECM 53. 
The third stage of osteoblast differentiation is associated with marked elevation of proteins 
associated with ordered deposition of hydroxyapatite and ECM mineralization and 
increased expression of associated genes (e.g. osteopontin, osteocalcin and bone 
sialoproteins) 53. This is followed by an editing/remodeling phase of extracellular matrix 
and the newly formed bone that is characterized by elevated expression of collagenase and 
type I collagen, increased apoptotic activities coupled with a compensatory stimulation of 
proliferative activity of osteoblasts 53.  
This model of osteoblast differentiation implies that there are two transitional points during 
the process of osteoblast differentiation 53.  The first transitional point, which is at the end 
of proliferation stage, there is a down regulation of genes of cell cycle and cell growth and 
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an increased expression of genes associated with matrix maturation. The second 
transitional point marks the onset of ECM mineralization 53. Although these stages are 
largely descriptive, biochemical studies indicate that factors inhibiting proliferation result 
in early onset mineralization 53 
Osteoblasts were found to synthesize a number of peptide growth factors including 
fibroblast growth factor (FGFs) 37, 39, 40, 54, insulin like growth factor (IGFs) 37, 39, 40, 55, 
transforming growth factor (TGFs) 37, 39, 56. 
 Platelet derived growth factor (PDGFs) 37, 39, 40, 57 bone morphogenic proteins (BMPs) 37, 
39, 58-60 and Wnt family of growth factors37, 61.These growth factors act in an autocrine or 
paracrine manner to alter the differentiation and/ or function of osteoblasts or other bone 
cells 40.They are later stored in the ECM and can eventually be released following 
osteoclastic bone resorption, in which they play a role in bone remodeling and repair 62. 
Fibroblast growth factors are a family of small peptide growth factors that are further 
divided into 6 sub-families according to their sequence and temporal pattern of expression 
63. They have been implicated in several cell functions including proliferation, 
differentiation, migration, mesodermal induction, and pattern formation and 
morphogenesis. They also play a role in angiogenesis, inflammation, wound healing, 
regeneration, cell survival and cancer growth 64. In skeletal tissues, FGF-2 is a major 
mitogenic growth factor for precursor cells, bone marrow stromal cells and osteoblasts 36, 
65, 66. In cultures, short-term treatment with FGFs was able to increase osteoblast 
replication, type I collagen synthesis, expression of alkaline phosphatase, osteocalcin, 
osteopontin and bone sialoproteins 67-69. However, long term treatment of osteoblasts with 
FGF-2 is detrimental for osteoblast differentiation and normal mineralization, it inhibits 
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overall bone tissue formation as osteoblasts will be trapped in the replication phase and 
will not enter the next phase of differentiation and mineral deposition 35, 36. It is believed 
that some of these effects on osteoblast function are due to FGF induced activation of 
Runx2 expression and phosphorylation. Runx2 which is also known as CBFA-1 is a 
transcription factor of the Runt-related family and it plays a central role in osteoblast 
differentiation 39. FGFs did not induce any changes of matrix degradation and bone 
resorption 39. Platelet derived growth factor (PDGF) is also synthesized by osteoblasts and 
is secreted as a dimer. This growth factor is encoded for by two genes PDGF A and B 39. 
PDGF was shown to stimulate proliferation of osteoblasts, which in turn secret collagen I, 
and matrix proteins leading to an overall increase of bone mass. Unlike FGFs, these growth 
factors enhance bone resorption and collagen degradation. They also play a role in tissue 
repair and wound healing 39. Insulin like growth factors (IGFs) I and II are also secreted by 
osteoblasts after their stimulation by growth factors and hormones (PTH and estrogen) 39. 
IGFs promote osteoblast replication, type I collagen production and matrix formation. 
However, their mitogenic effects were found to be weaker compared to other growth 
factors 39. 
Another group of growth factors also having a stimulatory effect on osteoblast proliferation 
and matrix production is transforming growth factor- (TGF-). These groups of growth 
factors were shown to increase expression of cell attachment proteins like fibronectin 39. 
Bone morphogenic proteins (BMPs) are members of the TGF- superfamily that play a 
central role in osteoblast differentiation and function 39. BMPs promote differentiation of 
bone progenitor cells to osteoblasts. They also increase alkaline phosphatase and 
osteocalcin production by mature osteoblasts 40. BMP-2 stimulates myoblastic cells to 
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differentiate into osteoblastic cells instead of differentiating into myotubes 70. A number of 
studies indicated that BMP-2 signaling activates canonical Wnt signaling and accumulation 
of -catenin 37. Lastly, Wnt signaling is also implicated in osteoblast development. 
Activation of canonical Wnt pathway proved to increase osteoblast number and ultimately 
bone mass 37. OPG production by osteoblast was upregulated by Wnt signaling.  
 
1.11 Complication around implants: 
 
 
Overdenture supported implants prosthodontics has been introduced as the standard of care 
for the edentulous patient. Single implants or multi-implants also started as an option for 
treatment for many patients. Implant treatment reached the peak and considered as the ideal 
treatment in many cases with missing teeth.  With this increase in use, many clinicians have 
noticed increase failure and complication. The Problems mainly fail into two 
classifications: after fixture placement or problem-related to surgery, and after loading or 
prosthetic problem. The problems associated with surgical placement include bone loss, 
infection, and violation of anatomical structure, improper angulation, and peri-implants. 
After loading complication includes screw loosening or fracture, porcelain fracture, 
abutment loosening, and prosthetic desponding. For both types, bone loss is the main 
complication even though it might be considered normal up to some extent. Bone 
remodeling is may be linked to recover or establish a biological width 71. Marginal bone 
loss around implants appears difficult to avoid, especially, after abutment connection, and 
minimal or no marginal bone loss following the implant–abutment connection is 
considered to be an indicator of the long-term success of implant restorations 72. Marginal 
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bone loss originates from a combination of mechanical and biological factors. Many factors 
have been hypothesized to answer for this problem, and include surgical trauma, peri-
implant micro-gap, and biological width and implant crest module 73. Marginal bone loss 
can started as mucositis and progress to peri-implantitis 74. Bone loss in two-stage implants 
takes place after abutment connection.  Factors involved in this type of implant include 
surgical complications, a less-than-ideal initial fits between the implant and the 
surrounding bone, insufficient bone volume to adequately surround the implant, early 
loading with resulting micro-movement of the implant prior to integration, Inadequate 
patient habits including tobacco product abuse, and healing impairment resulting from poor 
overall patient health 72. Many studies have evaluated bone loss after one year in function. 
Adell et al determined that the mean bone loss for Branemark Osseointegrated implants 
was 1.5 mm for the first year and followed by mean bone loss of 0.1 mm/year 75. 
Albrektsson et al showed that up to 2 mm of marginal bone loss around implant neck during 
the first year after functional loading is considered as implant success. Also, he showed 
that tissue stability is expected after one year of placement and should not exceed 0.2 mm 
per year that is regarded unwanted 76. On another hand, Papaspyridakos et al showed up to 
1.8 mm marginal bone loss in the first year is acceptable 77. Other claims that up to 1.5-
2mm is normal, and they suggested this is a good outcome 78. Marginal bone loss less than 
three threads has also been proposed as success criteria even though there are different 
implant system and inter-distance threads 79. Implant with the increased marginal bone loss 
at early stages are likely to reach marginal bone loss value that might compromise their 
outcome 80. The bone around implants plays a significant role in initial stability, and for 
this reason, the marginal bone loss is considered as a critical factor in implant success. 
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Many studies have shown that marginal bone loss varies in the distance with implants 
placement techniques and surfaces. The difference in marginal bone loss between different 
implant systems has been studied, however, few studies agreed on a minimal bone loss. In 
Per Astrand et al studies, they showed the difference between Astra implants and 
Branemark Implants in an early healing period 81. On follow-up for five years, the study 
showed there is no significant difference 82. Another study compared ITI dental implants 
with Branemark for three years and found no significant difference in marginal bone loss 
between these systems and the only difference in early healing stage was in bone 
remodeling 83. Biological width is another factor related to marginal bone loss. Herman et 
al 2001 concludes that the degree of inflammation in peri-implant tissues is less around 
one-piece implants compared to two-piece implants.  Also manipulating the soft tissue 
around the implant by removing the abutment and screw it again played a significant rule 
in bone loss around implants 84. Most of the studies published later were mainly looking 
for bone loss after loading. With different implant systems and surfaces, the question posed 
is do we see bone loss between the time placement and loading and before the 2nd stage 
surgery. Is it related to implant surface or design? Three implant systems were compared 
in this thesis to explore this phenomenon. Noble biocare, Straumann and 3i Biomet 
implants. One of the factors play an importnant rule in bone loss around implant is the 
design of the implant. Among forty years of implant discovery as a dental intervention, 
companies worked hard to implement the ideal design with no or minimal bone loss around 
the implant platform. Ten-year data for Branemark implants showed bone loss of 0.7mm 
in periodontally healthy subjects and 1.7 mm in subjects with advanced chronic 
periodontitis29, 30 
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1.12 Peri-implantitis: 
 
It is a biologic complication in which bone loss occurring around a dental implant is beyond 
what would be expected with physiologic modeling/remodeling of the crestal bone 
associated with its placement and healing. Peri-implantitis has been characterized by an 
inflammatory process around an implant, which includes both soft tissue inflammation and 
progressive loss of supporting bone beyond biological bone remodeling 85. Lindhe and 
Meyle mentioned seven risk factors that could be associated with this inflammatory disease 
86. Failure to treat this inflammatory disease has been a concern that has been occupying 
various clinicians since elimination this problem is a key factor in determining the 
prognosis of their patients 87, 88. 
 
1.13 Implant surface decontamination:  
 
The oxide level on commercially pure titanium is high, which makes it more favorable to 
adsorption of biomolecules and subsequently cellular attachment. Even a thin layer of any 
sort of contamination will diminish its capacity in adhesion along with diminishing its 
surface energy significantly 89. The more we re-expose and de-contaminate the titanium 
surface of the implant and make it more available for re-attachment to surrounding bone 
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tissue, the better chances we have for reestablishing osseointegration 90 since we have now 
a healthier tissue-implant interface with a freshly exposed oxide-layer 91. 
Decontamination of structured implant surfaces is difficult to achieve. Since mechanical 
methods (plastic curettes, polishing with rubber cups) alone have been proven to be 
insufficient in the elimination of bacteria on roughened implant surfaces, the adjunctive 
use of chemical agents (irrigation with local disinfectants, local or systemic antibiotic 
therapy) has been recommended in order to enhance healing following treatment 92,93.  
There are several ways mentioned in literature by various clinicians in which treatment of 
peri-implantitis was mentioned. Nonsurgical treatment is usually started with in an effort 
to eliminate the progressive bone loss seen on the failing dental implant. Unfortunately, 
this line of treatment has been reported to be unsuccessful 94. Some surgical strategies 
found the same results when were used without targeted antimicrobial therapies 95. This 
has led to algorithms emphasizing the removal of dental implants based on level of disease 
96 97.Since a primary factor in all peri-implantitis treatment protocols includes surface 
decontamination, all of these efforts may be related to an inability to decontaminate the 
dental implant’s surface. 
Froum et.al. 98 published a protocol for implant decontamination that has been tested 
clinically by several periodontitis and yielded some positive clinical outcomes showing 
some promising results in terms of reducing probing depths and bleeding on probing 99. In 
this protocol, treatment involves a combination of air powder abrasion with glycine powder 
(mechanical removal of debris), followed by 50% citric acid application and finalized by 
immediate, adequate flushing with sterile saline for two minutes 98. 
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2 Rationale and Clinical significance 
 
 
Zitzmann and Berglundh on behalf of the VI workshop of the European Federation of 
Periodontology have suggested that 28–56 percent of the patients and 12–43 percent of the 
implants will develop peri-implantitis during the years 100. Peri-implantitis is an irreversible 
disease that affects the investing tissues and bone surrounding a previously osseointegrated 
implant. The inflammatory component must be placed under control as a first step 101. Once 
the inflammatory process in the peri-implant tissues is under control, an attempt would be 
made to improve or re-establish osseointegration using regenerative procedures. All this 
aims to prolong the life of the placed implant. This study shone more light on one of the 
protocols used in clinical practice in the management of peri-implantitis that is widely used 
and published with great clinical outcomes 99. The study focused more on the efficacy of 
the cited technique on a microscopic level. 
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3 Hypothesis 
 
 
It was hypothesized that the decontamination protocol would efficiently remove 
contaminants from various implants’ surfaces, exposing titanium surface and re-establish 
a new bone-implant interface leading to enhancement of human osteoprogenitor cells 
attachment, proliferation and maturation. 
 
 
 
The null hypothesis 1 (H01) was that, there is no difference in cell attachment, proliferation 
and maturation in comparison before and after decontamination process. 
 
The null hypothesis 2 (H02) was that there is no difference on implants surface composition 
in comparison before and after decontamination process. 
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4 Specific Aims 
 
Aim 1: To compare between contaminated implants before and after decontamination 
process in terms of cellular attachment and proliferation.  
 
 
Aim 2: To measure the effect of decontamination treatment on both Titanium (Ti) and 
Oxygen (O) levels on the surfaces of implants.  
 
 
Aim 3: To prove technique efficacy in terms of removing deposits off implant surfaces by 
measuring deposits presence before and after. 
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5 Materials and Methods 
 
5.1 Comparison study with SEM imaging 
5.1.1 Cell culture preparation: 
 
The steps to obtain human pre-osteoblast cells were based on a previously published 
protocol 102. Tissue culture isolation and maintenance were performed entirely under the 
class II biological lab safety hood to ensure sterile conditions. Human intra-oral bone 
fragments were obtained through the oral surgery department at Boston University School 
of Dental Medicine. Bone samples were obtained from discarded tissue during dental teeth 
extraction and other ostectomy procedures. Bone samples were transported to the lab in a 
sterile container with cold phosphate buffered saline (PBS) containing antibiotics. In the 
lab, bone chips were minced into smaller pieces and washed with cold PBS plus antibiotics 
to remove blood components (Figure 5-1), and digested twice with 5ml of an enzyme 
cocktail for 15 min at 37o C in a shaking water bath (Figure 5-2). The enzyme cocktail was 
prepared by combining collagenase (3mg/ml) to separate fibroblasts and other cell lines, 
elastase (6.25 U/ml), chondroitin sulfate (6 mg/ml), penicillin (100U/ml), and D-sorbitol 
(18.22 mg/ml) in Kreb’s buffer solution. The Kreb’s solution was prepared by dissolving; 
126 mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, 1.2 mM NaH2PO4, 1.2 mM MgCl2, and 2.5 
mM CaCl2 in distilled water and adjusting the pH to (7.2). Then, the solution was sterile 
filtered. After enzymatic treatment, the bony chips were washed with cold PBS, and then 
cultured with phenol red-free DMEM/F12 (1:1) plus 10% (v/v) heat inactivated fetal 
bovine serum (FBS) and antibiotics (100U/ml). Primary cell culture in the size 12.5cm2 
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flask was allowed for 3-4 weeks until cells reached about 70-80% confluence (Figure 5-3). 
Culture media was changed every day for the first 10 days. The process of media change 
was as follows; first the old media is aspirated, then 10 ml of 1X PBS is added to rinse the 
surface of the flask and aspirated it, lastly 6 ml of new growth media is added. Bone 
fragments were kept in the flask for the first 7-10 days to allow cell migration from the 
bone and attaching to the flask surface. After that time, bone fragments were aspirated and 
discarded to allow the attached cells to grow freely on the flask surface and reduce the risk 
of microbial contamination. Osteoblasts from pre-confluent cultures were detached with 
0.25% Trypsin–1 mM EDTA (GibcoBRL, life Technologies, NY). Cells were centrifuged 
till pellet of cells in the bottom of the tube was evident after centrifugation, and the solution 
above the pellet containing the trypsin was carefully aspirated, and fresh media was 
replaced instead. The media with cells was then transferred, after re-suspension in the tube, 
using a pipette to be cultured in the 225cm2 flask with 75-80 ml of growth media. This 
secondary cell culture took about 2-3 weeks to reach a 70-80% confluence. The whole 
process would take approx. 6 weeks till we got healthy mature osteoprogenitor cells. Each 
large flask would have a cell count of approx. 1.48x107– 1.62x107 cells per flask. 
 
On the day of the experiment, cells were detached from each large flask using the same 
technique as previously in the first passage and suspended in solution of fresh DMEM. 
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Figure 5-1: Minced bone chips 
Immersed in PBS in preparation to cell culture. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2: minced bone chips in enzymatic treatment 
Enzymatic treatment in 37oC aimed to remove blood components  
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Figure 5-3: First passage cell culture 
Cells were allowed to proliferate for 4 weeks in sterile conditions 
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5.1.2 Implant preparation: 
 
A total of 16 implants were used in this experiment, which had IRB approval (H-33173).  
a) Test group: SIX explanted implants that were diagnosed with peri-implantitis, will 
receive the decontamination treatment protocol (Figure 5-4). 
b) Negative control: SIX explanted implants that were diagnosed with peri-
implantitis, WITHOUT receiving any decontamination treatment protocol 
c) Positive control: TWO explanted implants that were diagnosed with peri-
implantitis, receiving placebo treatment protocol (Figure 5-5). 
d) TWO Pristine implant/titanium surface (Fresh) 
 
The implants that were the subject of this study contained an anodized surface and were 
obtained from patients from the Department of Periodontics at The Henry M. Goldman 
School of Dental Medicine at Boston University in Boston, Massachusetts. All fixtures had 
been diagnosed with severe peri-implantitis and were determined by faculty members to 
require removal as a part of their overall care. Reverse torque, trephine or piezoelectric unit 
explanted the implants with care given to avoid damaging their surface. Each implant was 
received from the Periodontology department in a sealed envelope and was assigned a 
number. Blinded randomly, envelopes were chosen for different groups of study. All 
information regarding the anonymity of numbered samples were masked till the end of the 
study. To standardize clinical variation in treatment delivery, treatment was performed by 
one clinician (Dr. P Rosen) familiar with the protocol for surface decontamination that has 
met with clinical success as a in a regenerative technique in the treatment of peri-implantitis 
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in humans 98. Treatment was mentioned in literature and was mimicked word by word. The 
Test group (Figure 5-4) went through mechanical removal of large debris such as calculus 
and residual bone with ultrasonic and hand scalers instrumentation with care taken to avoid 
as much as possible deforming the implant surface. This was followed by Surface 
Decontamination using air powder abrasion with glycine powder (Air-n-Go, Acteon North 
America. Mount Laurel, New Jersey) for 1 minute followed by rinsing the implant with 
sterile water. The surface was then treated with citric acid (pH=1) in a 50% saturated 
solution that was burnished onto the surface with sterile cotton pellets for approximately 
thirty seconds to one minute followed by vigorously rinsing with sterile water for one to 
two minutes. Negative Control implants remained untreated with no efforts made to 
remove any of the surface contaminants. Positive Control implants (Figure 5-5) went 
through mechanical debridement as the test group followed by rubbing the surface with 
sterile water on cotton pallets for approximately two minutes in an attempt to remove any 
residual contaminants. All implants were then individually placed into sterile containers, 
labeled and transferred to the tissue culture lab. 
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Figure 5-4: Test Group before and after decontamination treatment 
 
A: Peri-implantitis diagnosed failed implant with contaminants on titanium surface. 
B: Same implant shown in “A” after decontamination process and removal of 
contaminants 
A 
B 
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Figure 5-5: Positive-Control group before and after decontamination treatment 
 
A: Contaminated implant before treatment with bone fragments and debris attached to it. 
B: Implant undergone mechanical debridement only followed by saline wash. As seen in 
the image there is remaining contaminants on titanium surface. 
A 
B 
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5.1.3 Cell seeding over dental implants: 
 
In order to find the best position for the implants to be seeded with previously prepared 
cells, a pilot study was done on titanium screws. Two proposed positioning methods were 
taken into consideration: a vertical and a horizontal position. Another factor that was 
questioned is the appropriate time for cells to be seeded on the surface of the implant before 
fixation. 21 titanium screws (ACE hardware corporation) were sterilized and used. 
For the horizontal group (Figure 5-6 A), 18 screws were placed in a 24-well plate, each 
positioned horizontally, and each screw was bathed with 1ml of cell suspended solution.  
To evaluate the ideal time in which screws should stay in contact with cells, to achieve the 
maximum amount of cellular attachment, 2,3,4,5 and 6 hours of seeding was tested. Every 
six screws (of 2,3,4,5&6 Hours seeding) were removed and placed in nourishing media 
solution for 24, 48 and 72 hours to determine the optimal duration of time in which cells 
would attach and elongate to its optimal condition. 
For the vertical group (Figure 5-6 B), 6 screws were used. Screws were placed vertically 
in a previously sterilized Eppendorf 2 ml tubes (Figure 5-7). Original covers were removed 
and replaced by breathable ones for incubation purposes. 1ml of suspended cells were 
transferred to tubes containing implants and were shaken vertically every 10 min for the 
total duration of an hour to overcome cell precipitation. Screws were removed, placed in a 
24-well plate and submerged in nourishing media solution for 24, 48 and 72 hours. 
After fixation (technique will be further discussed later), SEM images confirmed that the 
vertical technique of seeding for the duration of 72 hours yielded the best quantity/quality 
of cellular attachment of titanium alloy surface since it ensured uniform coating of the 
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screw. This was further confirmed with literature 103. It was decided that this would be the 
method of choice (Figure 5-6 B). 
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Figure 5-6: Cellular shape in both cell-seeding implant-positions 
A: Progenitor Cells seeded for 72 hours using the horizontal implant-position method. 
Cells are less attached and less proliferated than next image. 
B: Progenitor Cells are more in number and show better proliferation and attachment 
using vertical implant-position seeding for 72 hours 
A B 
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Figure 5-7: Vertical seeding with Eppendorf tube and breathing cover 
 
Implants were placed vertically and cells were seeded in a 1ml solution. Cells 
then placed and allowed to proliferate and attach for 72 hours before fixation.  
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A single individual (MQ) familiar with the protocol performed all lab work. Implants 
arrived to the cell-culture laboratory in individually, labeled, sterile test tubes. Previously 
sterile Eppendorf 2 ml tubes were used (Per pilot protocol) and implants were placed in 
them, vertically. Implants were bathed with 1 ml of suspended cells in solution for an hour 
with shaking them individually every 10 min. implants were later transferred to a 24-well 
plate and nourishing DMEM media was placed on them. Culture plates were stored in an 
incubator for the duration of 72 hours to allow for cellular proliferation to occur. The 
growth media was changed every day to ensure optimal cellular survival. 
 
After 72 hours, implants were removed from tubes and cellular fixation was done. Samples 
were then mounted on scanning electron microscope (SEM) discs and sputter coated with 
Palladium. A single individual performed imaging of each implant with analysis made of 
the top 5 mm of the implant from the flange, as this was an area consistently demonstrating 
bone loss in all cases.  
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5.1.4 Fixation: 
 
A modified technique of what was previously published in literature as cells fixation 
technique 104 was used in this study. 
a) Primary fixation using 2.5% Glutaraldehyde in pH 7.2 in temp of 4oC overnight. 
b) Secondary fixation using 4% osmium tetroxide in distilled water for 20 min in room 
temp. 
c) Dehydration using a sequence of different concentrations of ethanol (25%, 50%, 
75%, 95% and 100%) 
d) HDMS in conc. of 100% for 10 min. 
e) Specimens remained overnight in a fume hood covering with glass lid to air dry 
before sputter coating and mounting on SEM. 
 
 
5.1.5 SEM Evaluation: 
 
Gold/palladium sputter coating was done to all specimens. All images were taken in 
various magnifications (X50, X100, X200, X500) using FESEM (HITACHI SU6600) at 
an accelerated voltage of 15.0 kV and a working distance of 30 mm from the electron 
emission beam source. Images were distributed into electronic folders according to 
numbers that corresponded to samples numbers. 
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5.2 Quantitative study of various elements: 
 
5.2.1 EDX analysis: 
 
This part of the study focused more on the quantitative element of the protocol. Using the 
EDX analysis unit available in the SEM machine, we analyzed two factors: 
a) Percentages of Titanium (Ti) and Oxygen (O2) 
b) Presence of deposits (calculus, bone, calcium residues etc.)  
We had FOUR test implants that were contaminated and TWO control implants that were 
fresh from their containers. 
All 6 implants underwent the EDX analysis before the decontamination protocol and once 
again after the decontamination protocol.  
When mounted on SEM discs, a mark (Figure 5-8, 5-9) was made coronal and apical to the 
specimen and the disc to ensure the exact return of it after treatment so that the exact sites 
would be re-analyzed (Figure 5-10, 5-11). Each implant was examined in 3 random views 
(Figure 5-10 A, B, C). Each view had 5 sites that were analyzed. Implants were removed, 
underwent treatment and remounted to the exact same location on discs and exact views 
were reproduced and exact cites were analyzed (Figure 5-10 D, E, F). 
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Figure 5-8: 
Mounted 
implant 
specimen on 
SEM disk 
 
 
 
 
 
 
 
 
 
 
Implants are mounted on disks prior to EDX evaluation. Contaminants of implant 
surfaces are evident since they are prior to decontamination process 
Figure 5-9: Marking of implant after mount to reproduce location after treatment of 
implants 
Non-erasable marker was used on both disk and implant specimen in 2 different points to 
ensure reproducibility of repositioning of specimens after decontamination. EDX was 
performed before and after decontamination.  
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Figure 5-10: EDX analysis before 
decontamination 
A, B, C: Different positions of different 
implant surfaces prior to 
decontamination process, ready for EDX 
evaluation.  
 
 
 
 
Figure 5-11: EDX analysis after 
decontamination in the same sites 
D, E, F: Same positions of previously 
EDX scanned implant surfaces after 
decontamination. Marking both disk and 
implants ensured repositioning.
A D 
B 
E 
C 
F 
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5.2.2 Statistical analysis: 
5.2.2.1 Choosing the best analysis method: 
 
Analyzing statistical percentages of Oxygen and Titanium: 
 
The data consisted of relative frequencies of elements as percentages of the elemental 
composition of implants before and after decontamination method. The data was collected 
from 6 different implants (A, B, C, D, E, and F) four of which were already contaminated 
so they would represent the Test implants (A, B, C, and D) and two were fresh and never 
been placed in a patient and were used as Control implants (E and F). The data from each 
implant derived from three broad sites and each site has 5 index marks. This means that 
the data consisted of 15 index marks per implant. The elemental composition before and 
after the decontamination was measured on the same index marks. 
Given the description above, the data was clustered and consisted of multiple subgroups 
that are not necessarily independent from one another. For example, since every implant 
might have different elemental composition than other implants, the data that were derived 
from a particular implant might have had an inherent tendency to cluster around the 
elemental composition of this implant. Likewise, a discrepancy between the elemental 
composition on different sites or index marks across the same implant might create a 
similar phenomenon across those subgroups. In other words, all observations were 
probably not independent from one another and combining them without accounting for 
this would have created a considerable bias. 
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If the data across the different implants/sites/index marks were independent, the most 
simple univariate analysis would have been a simple t-test between pre- and post-
decontamination. If data across the different implants/sites were independent but the index 
mark pairs were not, the most simple univariate analysis would have been a paired t-test 
between pre- and post-decontamination. Before proceeding with such analyses, a test 
whether it was actually allowed to do so was needed. The data for a simple t-test could 
have only been combined if all the observations were independent from the other 
observations. Likewise, data for a paired t-test could have only been combined if all the 
paired observations were independent from the other paired observations. In other words, 
the variability between the groups that were combined (implant, site, index mark) should 
not have been significantly different than the variability across these groups. A test for this 
could have been performed by three serial ANOVAs across these groups. It was not needed 
to adjust for multiple testing since the main analysis was not performed but rather looking 
for the best approach to ensure eliminating possible biases. 
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Grouping by index markings 
 
One-way ANOVA analysis was performed to investigate whether there was variation in 
the before-decontamination Oxygen percentage that could be explained by grouping the 
data by index markings. 
            Df Sum Sq Mean Sq F value Pr(>F) 
   
index        1    594   594.4   4.315 0.0407 * 
Residuals   88  12124   137.8                  
 
 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
 
The p-value for the “index” variable is < 0.05. This meant that the within-index variability 
was different than the between-index variability and it could not have combined the several 
indexes without accounting for this. A graphical interpretation of these results could be 
explained in the following figure where, even though the data before and after 
decontamination had different clustering patterns, they did cluster in a way that could not 
be explained by the index mark grouping. There was rather a tendency of the data to cluster 
in each implant (6 clusters per plot, more prominently after the decontamination). 
 
 
 
 
 
Figure 5-12: Plot showing clustering pattern of Oxygen percentage values before 
decontamination 
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Figure 5-13: Plot showing clustering pattern of Oxygen percentage values after 
decontamination 
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Similar were the findings for the Titanium, as shown in the figure below. In this figure, 
even though the data before and after decontamination had different clustering patterns, 
they did cluster in a way that could not be explained by the index mark grouping. There 
was rather a tendency for the data to cluster in each implant (6 clusters per plot, more 
prominently after the decontamination). 
Figure 5-14: Plot showing clustering pattern of Titanium percentage values before 
decontamination 
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Figure 5-15: Plot showing clustering pattern of Titanium percentage values after 
decontamination 
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Grouping by broad site 
 
One-way ANOVA analysis was performed to investigate whether there was variation in 
the before-decontamination Oxygen percentage that could have been explained by 
grouping the data by broad site. 
            Df Sum Sq Mean Sq F value   Pr(>F)  
    
site        17   8349   491.1   8.092 7.19e-11 *** 
Residuals   72   4369    60.7                      
 
 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
 
The p-value for the “site” variable was < 0.05. This meant that the within-site variability 
was different than the between-site variability and it was not possible to combine the 
several sites without accounting for this. A graphical interpretation of these results could 
be explained in the following figure where, even though the data before and after 
decontamination have had different clustering patterns, they did cluster in a way that could 
not be explained by the site grouping. There was rather a tendency for the data to cluster 
in each implant (6 clusters per plot, more prominently after the decontamination). 
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Figure 5-16: Box plots showing Oxygen clusters distribution before 
decontamination.  
Note that each letter represents an implant and each number represents a different site on 
that specific implant 
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Figure 5-17: Box plots showing Oxygen clusters distribution after decontamination. 
Note that each letter represents an implant and each number represents a different 
site on that specific implant 
 
*Little dots represent outliers 
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Similar were the findings for the Titanium, as shown in the figure below. In this figure, 
even though the data before and after decontamination had different clustering patterns, 
they did cluster in a way that could not have been explained by the site grouping. There 
was rather a tendency for the data to cluster in each implant (6 clusters per plot, more 
prominently after the decontamination).  
 
Figure 5-18: Box plots showing Titanium clusters distribution before 
decontamination.  
Note that each letter represents an implant and each number represents a different site on 
that specific implant 
 
 
*Little dots represent outliers 
A1 A2 A3 B1 B2 B3 C1 C2 C3 D1 D2 D3 E1 E2 E3 F1 F2 F3
0
2
0
4
0
6
0
8
0
1
0
0
T
it
a
n
iu
m
 (
%
) 
a
ft
e
r 
d
e
c
o
n
ta
m
in
a
ti
o
n
  50 
 
Figure 5-19: Box plots showing Titanium clusters distribution after 
decontamination.  
Note that each letter represents an implant and each number represents a different site on 
that specific implant 
 
*Little dots represent outliers 
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Grouping by implant 
 
One-way ANOVA analysis was performed to investigate whether there was a variation in 
the before-decontamination Oxygen percentage that can be explained by grouping the data 
by implants. 
            Df Sum Sq Mean Sq F value   Pr(>F) 
     
implant      5   6120  1224.1   15.58 7.93e-11 *** 
Residuals   84   6598    78.5                      
 
 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
The p-value for the “implant” variable was < 0.05. This meant that the within-implant 
variability was different than the between-implant variability and it was not possible to 
combine the several implants without accounting for this. A graphical interpretation of 
these results could have been explained in the following figure where, even though the data 
before and after decontamination have had different clustering patterns, they did cluster in 
a way that could be explained by the implant grouping. 
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Figure 5-20: Box plot showing Oxygen percentages clusters before decontamination.  
Note that each letter represents an implant 
 
*Little dots represent outliers 
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Figure 5-21: Box plot showing Oxygen percentages clusters after 
decontamination.  
Note that each letter represents an implant 
 
*Little dots represent outliers 
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Similar were the findings for the Titanium, as shown in the figure below. The data clustered 
in a way that could be explained by the implant grouping. 
 
 
 
Figure 5-22: Box plot showing Oxygen percentages clusters before decontamination.  
Note that each letter represents an implant 
 
*Little dots represent outliers 
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Figure 5-23: Box plot showing Oxygen percentages clusters before decontamination.  
Note that each letter represents an implant 
 
*Little dots represent outliers 
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Analyzing statistical presence of deposits: 
 
In the following plots, it was evident that the grouping of the data on index mark, site, or 
implant did not affect significantly the deposits. They seemed to follow the same pattern 
irrespectively of the grouping. The pattern seemed to be that the Test implants had no 
deposits prior to decontamination whereas, in reality, the Test implants had deposits. On 
the leftmost plots, it depicted the deposits before decontamination and on the rightmost 
plots the deposits after decontamination. 
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Grouping by site 
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Grouping by implant 
 
 
 
Figure 5-24: A, B, C different plots showing that there was no difference by 
grouping the data on deposits. 
 
 
A: Clusters of deposits before and after decontamination. Top line represents “YES” for 
deposits presents and lower line represents “NO” for deposits absence. 
 
B: Each bar represents a site on a different implant. Light grey represents “YES” and dark 
grey represents “NO” to deposits presence. 
Left plots represent before and right plots represent after decontamination 
 
C: Each bar represents an implant. Light grey represents “YES” and dark grey represents 
“NO” to deposits presence. 
Left plots represent before and right plots represent after decontamination 
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5.2.2.2 Decision on final analysis 
 
Final statistical analysis chosen for Oxygen and Titanium percentages 
 
 
In short, above it has been shown that a simple or paired t-test could not be performed 
between before and after decontamination because the observations seemed to be mainly 
implant-dependent. From the graphs, it has been evident that there was a tendency of the 
data to cluster in each implant. It also seemed logical that every implant might have had an 
inherent different elemental composition for Oxygen or Titanium in comparison to other 
implants. The best way to have analyzed the data, where the dependent variable was 
continuous, and grouping on multiple levels (test, control), is ANOVA: 
 Two-way ANOVA of Oxygen (dependent variable) on test implant and 
decontamination protocol. 
 Two-way ANOVA of Oxygen (dependent variable) on control implant and 
decontamination protocol. 
 Two-way ANOVA of Titanium (dependent variable) on test implant and 
decontamination protocol. 
 Two-way ANOVA of Titanium (dependent variable) on control implant and 
decontamination protocol. 
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Final statistical analysis chosen to measure presence of Deposits 
 
The deposit variable, in contrast to the Oxygen and Titanium, was binary. The deposit 
variable seemed to be mainly implant-dependent. Logistic regression allowed performing 
this analysis. Logistic regression of deposits was performed (dependent variable) as a 
function of decontamination (protocol), after it was adjusted for test and control. 
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6 Results 
6.1 Descriptive Comparison study with SEM imaging 
There was no loss due to contamination or failure in processing any of the samples. 
 
a) Test group: 
 
The test surfaces that received the air powder, citric acid decontamination followed by 
neutralization with sterile saline, were considerably different. While all of these implants 
also demonstrated the classic anodized surface morphology, all were absent of any smear 
layer. Two of the implants were viewed after 24 hours of seeding and Scattered 
osteoprogenitor cells could be seen as early as 24 hours and increased in number 
throughout the 72-hour time frame. The attached osteoprogenitor cells demonstrated an 
elongated morphology to them that, in some cases, bridging the titanium threads. This 
cellular morphology with their extended projections was suggestive of healthy attachment 
and proliferation. There was no evidence of smear layer or Calculus/Bone deposits on 
surface. Homogenous layer of progenitor cells were predominating the scene in every 
magnification.  
 
 At X50 magnification (Figure 6-1-A): 
 
Implant surface at the level of the first five threads, showed an abundance amount of cells 
in the forms of layers. Surface shows high affinity to cells and threads are covered with 
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multiple layers of bridging cells. There was no evidence of any deposits on surface and no 
evidence of smear layer as well. 
 
 At X200 magnification (Figure 6-1-B): 
 
Cells are in close proximity to each other with elongated projections that are connecting 
cells to each other. We can also see some cells bridging from a point to another where it is 
suggestive of healthy new attachment. 
 
 At X500 magnification (Figure 6-1-C): 
Cells look healthy with wide contact points in their periphery on titanium surface 
suggesting higher contact points between implants and cells. No evidence of any foreign 
material competing with cells over surface area. No evidence of deposits mimicking 
calculus/bone. 
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Figure 6-1: SEM Test group images of titanium surfaces 
    
 
 (A): SEM 50X magnification of 3 different implant surfaces with condensed layers 
of osteoprogentor cells that are attached to surface after decontamination. 
 (B): SEM 200X magnification of 3 different implant surfaces with homogenous 
bridging of cells on decontaminated surfaces. 
 (C): SEM 500X magnification of 3 different implant surfaces with maturly attached 
progenitor cells that are elongated and well anchored on titanium surface. 
A 
B 
C 
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b) Negative control:   
 
The control or untreated group did not receive any treatment and was mimicking in essence, 
an untreated implant in a patient’s mouth. It displayed the characteristic pattern associated 
with the anodized implant surface preparation.  Foreign material/smear layer was still 
remaining adherent on the entire surface of the implant (Figure 6-2). No osteoprogenitor 
cells were seen either attaching to or proliferating on the surfaces exposed to the oral 
environment throughout the entire 24-72 hour time frame of the study.  
 
 At X50 magnification (Figure 6-3-A) 
 
Surfaces of 3 different implants (Figure 6-3-A 1,2 and 3) show layers of deposits scattered 
all over. Smear layer is covering the surface of the implant. No evidence of cellular 
deposition on surfaces.  
 
 At X200 magnification (Figure 6-3-B) 
 
Magnification of surfaces shows different implant surfaces (Figure 6-3-B 1,2 and 3) with 
foreign bodies attached to it. Barren titanium surface shows no evidence of cellular 
attachment on it. Some samples showed bacterial colonies attached to titanium surfaces. 
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 At X500 magnification (Figure 6-3-C) 
 
Different implant surfaces have no evidence of any cellular attachment (Figure 6-3-C 1,2 
and 3). Titanium surface has some layers of deposits attached to it. Difficult to find an 
exposed titanium surface since smear layer/deposits are covering the whole surface. 
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Figure 6-2: Bacterial colonies and foreign bodies deposits on contaminated implant 
surface at SEM 500X 
 
A: SEM image showing a bacterial cluster competing with a progenitor cell over 
attachment site on titanium surface. 
B: foreign body attached with no evidence of cellular attachment on titanium surface. 
C: Deposits that could be calculus tangled with bacterial clusters in an implant groove. 
D: image showing deposits competing for attachment sites with progenitor cells on 
titanium surface. 
 
 
 
 
A B 
C 
D 
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Figure 6-3: SEM Negative- Control group images of titanium surfaces for 3 
different implants 1,2 and 3 
B 
A 
C 
 
 A): SEM 50X magnification of various implants surfaces (1,2 and 3) with 
condensed layers of contaminants  that are attached to surface without any 
decontamination. 
 (B): SEM 200X magnification of different implant surfaces (1,2 and 3) with 
absence of osteoproginitor cells. 
 (C): SEM 500X magnification of different implant surface surfaces (1,2 and 3) with 
osteoprogenitor-free surfaces showing dome evidence of deposits. 
 
1 2 3 
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c) Positive control:  
 
These implants received a placebo treatment in which they were mechanically debrided 
and washed with sterile saline and they have demonstrated the characteristic pattern of the 
anodized implant’s surface. In lower magnification, some osteoprogenitor cells are 
suggested to be attaching to the surface, however, their attachment to the surface is few 
and far between. Looking at the higher magnification, they appears unhealthy and not 
attached ion an even surface. 
 
 At X200 magnification (Figure 6-4-B) 
 
Implant surface shows less deposit than contaminated implant surfaces. No visible large 
clumps of deposits but there is a smear layer covering implant surface, evenly, preventing 
titanium from getting exposed 100% to the cellular environment. 
 
 At X500 magnification (Figure 6-4-A) 
 
Implant surface shows the exact anodized pattern of implant with a thin layer of smear 
layer covering some of the titanium grids. No cells were found attached to titanium surface  
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Figure 6-4: SEM Positive - Control group images of titanium surfaces 
A 
B 
 
(A): SEM 500X image showing no osteoprogenitor cells on mechanically debrided 
surfaces. 
(B): SEM 200X image showing implant surface with absence of progenitor cells and 
deposits as well 
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d) TWO Pristine implant/titanium surface (Fresh Implants): 
 
These implants underwent the whole treatment after taking them out from their own 
containers. They have demonstrated a clean surface free of any smear layer or even 
deposits. They showed cellular attachment on an even surface with comparable amount of 
cells to the test group. These implants demonstrated fewer cells than test but were more 
than control group. 
 
 AT X50 magnification (Figure 6-5-A) 
 
Two different Implant surfaces are free of any deposits or smear layer. Scattered cells are 
shown evenly on entire implants surfaces evenly distributed. 
 
 At X100 magnification (Figure 6-5-B) 
 
Groups of cells are attached to implant surface but not as much as test group. These cells 
groups keep distance from one group to the other and are not heavily populating entire 
implant surface. 
 
 At X500 magnification (Figure 6-5-C) 
 
Cells show complete maturity and healthy shape with extended projections and well-
attached periphery. Cells have normal shape with evidence of bridging over threads. Cell 
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number is less in condensation that test group but much more and healthier than both 
control groups. 
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Figure 6-5: SEM Positive - Control group images of two different implants (1 and 2) 
titanium surfaces A 
B 
C 
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 (A): SEM 50X magnification of various implants surfaces with lightly scattered 
cells that are evenly distributed on implant surface. 
 (B): SEM 200X magnification of implant surface with few matured cells that are 
well attached to titanium surface. We can also find no deposits anywhere since they 
are pristine implants. 
 (C): SEM 500X magnification of implant surface with osteoprogenitor cells that 
are well distributed, matured and attached on titanium surface. 
 
1 2 
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6.2 Quantitative Analysis study of various elements: 
 
 
Descriptive statistics 
 
The table next, corresponds to the so-called wide format of the data. In this format, Oxygen, 
Titanium and deposits are divided to: before decontamination (variables “O.1”, “Ti.1”, and 
“deposits.1”) and after decontamination (variables “O.2”, “Ti.2”, and “deposits.2”). 
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Table 6-1: Descriptive Statistics of data: 
 
 
Implant Site Index O% Before Ti% Before 
Deposits 
Before 
O% After Ti% After 
Deposits 
After 
Test/Control 
  A:15 A1: 5 Min.: 1.00 Min.   :23.16 Min.   : 7.94   n:37 Min.   : 5.19 Min.   :17.08 n:82 
B:15 A2: 5 1st Qu.:23.25 1st Qu.:47.62 1st Qu.:26.57   y:53 1st Qu.:41.63 1st Qu.:32.65 y: 8 
Test: 60 
Control: 30 
C:15 A3: 5 Median :45.50 Median :54.18 Median :35.90  Median :53.83 Median :45.59  
D:15 B1: 5 Mean   :45.50 Mean   :53.60 Mean   :34.65  Mean   :49.33 Mean   :53.26  
E:15 B2: 5 3rd Qu.:67.75 3rd Qu.:60.67 3rd Qu.:44.03  3rd Qu.:63.82 3rd Qu.:82.13  
F:15 B3: 5 Max.   :90.00 Max.   :86.21 Max.   :59.61  Max.   :88.70 Max.   :90.00  
 All: 60        
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The table below corresponds to the so-called long format of the data. In this format, Oxygen, Titanium and deposits are combined, in 
regards of before and after decontamination, and an additional variable called “decontamination” is used to differentiate the status before 
and after the decontamination.  
 
 
 
Table 6-2: Descriptive Analysis with combined data before and after decontamination: 
 
Implant Site Index Decontamination O% Ti% Deposits Test/Control 
A: 30 A1     : 10 Min.   : 1.0 Before :90 Min.   : 5.19 Min.   : 7.94 n:119 Control: 60 
B: 30 A2     : 10 1st Qu.:23.0 After :90 1st Qu.:43.80 1st Qu.:28.89 y: 61 Test   :120 
C: 30 A3     : 10 Median :45.5  Median :54.09 Median :40.46   
D: 30 B1     : 10 Mean   :45.5  Mean   :51.46 Mean   :43.95   
E: 30 B2     : 10 3rd Qu.:68.0  3rd Qu.:62.29 3rd Qu.:49.14   
F: 30 B3     : 10 Max.   :90.0  Max.   :88.70 Max.   :90.00   
 (Other):120       
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In the histograms below it shows the distribution of the Oxygen and Titanium before and 
after decontamination. The distribution of data follows normality before the 
decontamination but not after decontamination. 
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In the bar plots below, the presence of deposits (yes, no) is shown before and after 
decontamination. 
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6.2.1 Statistical analysis measuring percentage of Oxygen 
 
Two-way ANOVA (Oxygen as function of implant and decontamination) 
 
Two-way ANOVA was performed, analyzing the Oxygen percentage before and after 
decontamination as function of implants (A, B, C, D, E and F) and decontamination 
(protocol). 
 
 
                         Df Sum Sq Mean Sq F value  Pr(>F)     
decontamination           1    819     819   8.158 0.00483 **  
implant                   5  28718    5744  57.190 < 2e-16 *** 
decontamination:implant   5  15349    3070  30.566 < 2e-16 *** 
Residuals               168  16873     100                     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
It is shown that there is an interaction between implant and decontamination. The variables 
“decontamination” and “implant” are also statistically significant but, since there is a 
significant interaction, the interpretation of this analysis is made upon the interpretation of 
the interaction. In the interaction plot below, we can see that the lines are not parallel but 
instead they are crossing; this confirms visually the presence of the interaction that we 
found above. 
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Figure 6-6: Plot showing an interaction with decontamination protocol affecting 
each implant 
 
 
In other words, the oxygen percentage of implants before and after decontamination 
method is different across the various implants (p < 0.001). The effect of the 
decontamination on each implant was calculated by two post-hoc one-way ANOVAs (one 
ANOVA dropping the “decontamination” and another dropping the “implant” variable). 
These analyses were corrected for multiple testing. The results are not shown for simplicity 
reasons. The Mean Oxygen percentage of each implant before and after decontamination 
was estimated: 
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Table 6-3: Mean and SD of Oxygen% before and after treatment 
 
 
Before 
decontamination 
 After decontamination 
  Mean SD Mean SD 
Oxygen Percentage (%) 
    
Implant A 42.01 8.29 7.33 1.42 
Implant B 56.29 7.29 46.77 6.63 
Implant C 66.94 13.84 61.25 3.75 
Implant D 46.00 10.33 69.73 24.94 
Implant E 51.57 5.77 63.39 3.72 
Implant F 58.78 4.21 47.51 6.14 
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A graphical depiction of the above table is shown in the following boxplots (medians, the 
error bars correspond to interquartile ranges). Yes/no in x-axis indicates whether 
decontamination has been performed or not. 
 
 
 
 
Figure 6-7: Mean, Median and SD of Oxygen% before and after decontamination 
 
*Little dots represent outliers
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Two-way ANOVA (oxygen as function of prior use and decontamination) 
 
A two-way ANOVA was performed, analyzing Oxygen percentage before and after 
decontamination as function of prior-use (being test or control) and decontamination 
(protocol). 
 
                           Df Sum Sq Mean Sq F value Pr(>F)   
Decontamination             1    819   819.3   2.438  0.120   
Prior use                   1   1332  1332.1   3.964  0.048 * 
Decontamination:prior.use   1    465   464.6   1.382  0.241   
Residuals                 176  59143   336.0                  
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
 
We can see that the prior-use is barely significant (p = 0.048) and that there is no interaction 
between contamination and prior use. In the interaction plot below, we see that the lines 
are almost parallel. 
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Figure 6-8: Plot showing the effect of decontamination on Oxygen% in both groups 
 
 
In other words, the oxygen composition of implants before and after our decontamination 
method is barely different between test and control implants (p = 0.048). The effect of the 
decontamination on test and control implants was calculated by two post-hoc one-way 
ANOVAs (one ANOVA dropping the “decontamination” and another dropping the 
“prior.use” variable). These analyses were corrected for multiple testing. The results are 
not shown for simplicity. The mean oxygen percentage between test and control implants 
was estimated, before and after decontamination: 
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Table 6-4:  Mean and SD of Oxygen% before and after treatment between groups 
 
 
 
Before 
decontamination 
 After decontamination 
  Mean SD Mean SD 
Oxygen Percentage (%) 
    
Control implants 55.17 6.17 55.45 9.50 
Test implants 52.81 13.96 46.27 27.28 
 
 
A graphical depiction of the above table is shown in the following boxplots (medians, the 
error bars correspond to interquartile ranges). 
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Diagnostics / Testing assumptions 
 
The data on Oxygen percentages was analyzed using two-way ANOVA. Two-way 
ANOVA is a category of MANOVA. MANOVA assumes multivariate normality. In order 
to test for the presence of multivariate normality, it was computed that the Mahalanobis 
distances and presented them in a QQ plot. If the points in the plot tend to fall along a 
straight line, the plot suggests that the data follows multivariate normality. Because the 
samples contain a small number of points (180 for this data), a "perfect fit" should not be 
expected even if the data indeed follows multivariate normality. 
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Two-way ANOVA of Oxygen percentage on implant (A, B, C, D, E or F) and 
decontamination (protocol) 
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Two-way ANOVA of Oxygen percentage on prior use (test or control) and 
decontamination (protocol) 
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6.2.2 Statistical analysis measuring percentage of Titanium: 
 
Two-way ANOVA (Titanium as function of implant and decontamination) 
 
A two-way ANOVA was performed on titanium percentages before and after 
decontamination as a function of implants (A, B, C, D, E and F) and decontamination 
(protocol). 
 
                         Df Sum Sq Mean Sq F value Pr(>F)     
decontamination           1  15589   15589  275.12 <2e-16 *** 
implant                   5  31923    6385  112.68 <2e-16 *** 
decontamination:implant   5  23391    4678   82.56 <2e-16 *** 
Residuals               168   9519      57                    
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
 
An interaction between implant and decontamination is evident. The variables 
“decontamination” and “implant” are also statistically significant but, since there is a 
significant interaction, the interpretation of this analysis is made upon the interpretation of 
the interaction. In the interaction plot below, we can see that the lines are not parallel but 
instead they are crossing; this confirms visually the presence of the interaction that we 
found above. 
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Figure 6-10: Plot showing the effect of decontamination treatment on Titanium% in 
all implants 
 
 
In other words, the titanium percentage of implants before and after our decontamination 
method is different across the various implants (p < 0.001). The effect of the 
decontamination on each implant was calculated by two post-hoc one-way ANOVAs (one 
ANOVA dropping the “decontamination” and another dropping the “implant” variable). 
These analyses were corrected for multiple testing. The results are not shown for simplicity 
reasons. The mean of Titanium percentage of each implant before and after 
decontamination was estimated: 
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Table 6-5: Mean and SD of Titanium% before and after decontamination 
 
 
 
 
Before 
decontamination 
 After decontamination  
  Mean SD Mean SD 
Titanium Percentage (%) 
    
Implant A 40.45 9.82 84.69 3.36 
Implant B 21.20 5.18 45.73 4.72 
Implant C 31.10 13.30 31.40 3.71 
Implant D 38.37 13.90 85.92 3.64 
Implant E 41.78 6.94 25.80 5.00 
Implant F 34.99 4.35 46.02 5.83 
 
 
  92 
A graphical depiction of the above table is shown in the following boxplots (medians, the 
error bars correspond to interquartile ranges). Yes/no in x-axis indicates whether 
decontamination has been performed or not. 
 
 
 
 
Figure 6-11: Mean, Median and SD of Titanium% before and after decontamination 
 
* Little dots represent outlier  
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Two-way ANOVA (Titanium as function of prior use and decontamination) 
 
A two-way ANOVA of titanium percentage was performed before and after 
decontamination as a function of prior use (being a test or control implant) and 
decontamination (protocol done). 
 
                           Df Sum Sq Mean Sq F value   Pr(>F)     
decontamination             1  15589   15589   54.16 6.79e-12 *** 
prior.use                   1   4169    4169   14.48 0.000195 *** 
decontamination:prior.use   1  10004   10004   34.76 1.87e-08 *** 
Residuals                 176  50660     288                      
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
 
 
An interaction between prior use and decontamination is evident. The variable 
“decontamination” is also statistically significant but, since there is a significant 
interaction, the interpretation of this analysis is made upon the interpretation of the 
interaction. In the interaction plot below, we can see that the lines are not parallel but 
instead they are crossing; this confirms visually the presence of the interaction that we 
found above. 
 
 
 
Figure 6-12: Plot showing the effect of decontamination on Titanium% in both 
groups 
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Figure 6-13: Plot showing the effect of decontamination on Titanium% in both 
groups 
 
In other words, the titanium percentage of implants before and after our decontamination 
method is different between test and control implants (p < 0.001). The effect of the 
decontamination on test and control implants was calculated by two post-hoc one-way 
ANOVAs (one ANOVA dropping the “decontamination” and another dropping the 
“prior.use” variable). These analyses were corrected for multiple testing. The results are 
not shown for simplicity reasons. The mean titanium percentage between test and control 
implants was estimated, before and after decontamination: 
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Table 6-6: Mean and SD of Titanium% before and after treatment between groups 
 
 
 
Before 
decontamination 
 
After 
decontamination 
 
  Mean SD Mean SD 
Titanium Percentage (%) 
    
Control implants 38.38 6.66 35.91 11.58 
Used implants 32.78 13.22 61.93 24.42 
 
A graphical depiction of the above table is shown in the following boxplots (medians, the 
error bars correspond to interquartile ranges). 
 
 
 
 
Figure 6-14: Mean, Median and SD of Titanium% before and after decontamination 
between groups
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Diagnostics / Testing assumptions 
 
The data on Titanium percentage was analyzed using two-way ANOVA. Two-way 
ANOVA is a category of MANOVA. MANOVA assumes multivariate normality. In order 
to test for the presence of multivariate normality, we computed the Mahalanobis distances 
and presented them in a QQ plot. If the points in the plot tend to fall along a straight line, 
the plot suggests that the data follows multivariate normality. Because the samples contain 
a small number of points (180 for our data), we should not expect a "perfect fit" even if the 
data indeed follow multivariate normality. 
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Two-way ANOVA of Titanium percentage on implant (A,B,C,D,E or F) and 
decontamination (protocol) 
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Two-way ANOVA of Titanium percentage on prior use (being test or control) and 
decontamination (protocol) 
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6.2.3 Statistical analysis measuring presence or absence of Deposits: 
 
Unadjusted logistic regression 
 
We performed logistic regression of before and after decontamination deposits (dependent 
variable) as a function of decontamination. 
 
Coefficients: 
                   Estimate Std. Error t value Pr(>|t|)     
(Intercept)          0.58889    0.04260  13.822  < 2e-16 *** 
decontamination:yes -0.50000    0.06025  -8.299 2.54e-14 *** 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
(Dispersion parameter for Gaussian family taken to be 0.1633583) 
 
Null deviance: 40.328  on 179  degrees of freedom 
Residual deviance: 29.078  on 178  degrees of freedom 
AIC: 188.68 
 
Number of Fisher Scoring iterations: 2 
 
       (Intercept) decontamination yes  
         1.8019851          0.6065307  
 
                      2.5%             97.5% 
(Intercept)         1.657627         1.9589155 
decontamination yes 0.538973         0.6825564 
 
From the output above, it is evident that in the unadjusted analysis, the decontamination 
was associated with lower odds for the presence of deposits on the surface of the implant 
(OR 0.61; 95% CI 0.54 - 0.69; p value < 0.001). 
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Adjusted logistic regression 
 
A logistic regression was performed of deposits (dependent variable), before and after 
decontamination, as a function of decontamination adjusting for implant (A, B, C, D, E or 
F), and prior use (being a test or control). 
 
Coefficients: (1 not defined because of singularities) 
                     Estimate Std. Error t value Pr(>|t|)     
(Intercept)         7.500e-01  6.130e-02  12.235  < 2e-16 *** 
 
Decontamination:yes-5.000e-01  4.634e-02 -10.790  < 2e-16 *** 
implantB            2.000e-01  8.026e-02   2.492   0.0136 *   
implantC           -2.266e-16  8.026e-02   0.000   1.0000     
implantD           -1.667e-01  8.026e-02  -2.077   0.0393 *   
implantE           -5.000e-01  8.026e-02  -6.230 3.45e-09 *** 
implantF           -5.000e-01  8.026e-02  -6.230 3.45e-09 *** 
prior.use:Test             NA         NA      NA       NA     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
 
(Dispersion parameter for Gaussian family taken to be 0.09662813) 
 Null deviance: 40.328  on 179  degrees of freedom 
Residual deviance: 16.717  on 173  degrees of freedom 
AIC: 99.039 
 
Number of Fisher Scoring iterations: 2 
 
(Intercept)Decontamination:yes   implantB        implantC  
  2.1170000          0.6065307   1.2214028       1.0000000  
   implantD           implantE    implantF   prior.use:Test  
  0.8464817          0.6065307   0.6065307              NA  
 
                       2.5 %    97.5 % 
(Intercept)         1.8773347 2.3872616 
decontamination yes 0.5538715 0.6641964 
implantB            1.0436151 1.4294779 
implantC            0.8544398 1.1703575 
implantD            0.7232677 0.9906862 
implantE            0.5182439 0.7098577 
implantF            0.5182439 0.7098577 
prior.use: Test            NA        NA 
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From the output above, it is evident that in the adjusted analysis, the decontamination was 
associated with lower odds for the presence of deposits on the surface of the implant (OR 
0.61; 95% CI 0.55 - 0.66, p value < 0.001). The adjusted analysis did not change 
significantly the findings. This means that the effect of decontamination on deposits was 
more powerful than the potential effect of implant (variability of A, B, C, D, E or F) or 
prior use (being test or control) on deposits. 
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7 Discussion  
 
Dental implants are the gold standard in terms of replacing missing teeth and it has been 
the first choice to both patients and practitioners for the past two decades 105. Unfortunately, 
they are not immune to peri-implantitis, which could cause implant failure if left untreated 
106. It is defined as destructive inflammatory processes around osseointegrated implants in 
function that lead to peri-implant pocket formation and loss of supporting bone. There are 
several proposed treatments for peri-implantitis. They all range between non-surgical to 
surgical option. In this study, we looked deeply into one of the proposed treatment 
modalities that were published widely in literature 98.  
This study aimed to analyze the efficacy of decontamination the implant surface that was 
previously osseointegrated but was later on diagnosed with Peri-implantitis. The protocol 
aims to decontaminate the surface by mechanical debridement to remove deposits and 
remaining calculus. Followed by air abrasion using glycine powder to further remove any 
residual plaque, calculus, and biofilm from the macro- and microstructure of the implant. 
The use of glycine is selected versus sodium bicarbonate to avoid the potential for a foreign 
body reaction should residual particles remain at the end of the procedure. This is followed 
by the vigorous rubbing of the exposed implant surface with a saturated solution of 50% 
citric acid facilitates the removal of any residual organic debris from the surface which 
may include the glycine powder itself. Citric acid has also been shown as both a means to 
successfully decontaminate root surfaces affected by periodontitis 107 as well as helping to 
stabilize a clot 108 to the implant surface. This is followed by an immediate wash using 
sterile saline solution.  
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In this study we believe that the explanation, of positive results that were reported, is 
covered and the efficiency of this technique is tested and statistically proved. Our intent 
was also to provide proof of principle determination as to whether or not the implant’s 
surface could support the reattachment and proliferation of the osteoprogenitor cells.
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7.1 Comparison study with SEM imaging 
 
 
From the results of our study, we can see clearly the difference between our test group and 
both control groups in terms of cellular attachment. The decontamination protocol has 
possibly turned the implant surfaces to have higher affinity to cellular attachment when 
compared to the contaminated surfaces.  
 
Test group underwent the protocol that removed the smear layer from the surfaces, 
exposing more titanium surface to be exposed to cellular load for more attachment.  
The application of the 50% citric acid on the titanium surface followed by the sterilized 
saline, could explain the turning of the hydrophobic surface into a hydrophilic one 20. This 
newly turned hydrophilic surface has higher affinity to cellular attachment, proliferation 
and maturation than a hydrophobic surface that has hydrocarbon components attached to it 
15. The images in this group show homogenous attachment of cells on the surfaces of 
titanium as if reattachment was awaited once titanium surfaces were decontaminated. Some 
would suggest that a shortcoming in the current study is a lack of quantification being 
provided as to the number of osteoprogenitor cells present for a given area. But a general 
observation of these images shows the dramatic difference in cellular attachment between 
several groups, which would add more knowledge knowing its quantity, but this will be 
left to further studies in this field. 
The hydrophilic surface showed large amount of cellular attachment on its surface and that 
could explain the positive results since mechanical properties of titanium itself, could not 
be changed by merely adding citric acid.  
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Negative control images, in lower magnification, show layers of deposits attached to the 
surface of titanium, which prevented cellular attachment. And going to the higher 
magnification, we can clearly notice that the surface has no cells attached to it possibly 
because of the smear layer that comprises of bacterial byproducts and hydrocarbon 
remnants of previously attached cells. The aim of this decontamination process attempts to 
successfully treat a bacterially contaminated dental implant not only by eliminating the 
microorganisms but additionally, their cytotoxic byproducts and elements as well, enabling 
both a blood clot to stabilize and osteoblasts to attach and proliferate. The lack of such 
decontamination prevented our seeded osteoprogenitor cells from re-attaching and 
proliferating on titanium surfaces.  
  
Looking at the positive control group, where we mainly mechanically debrided the surface 
of the titanium only, we found that there are few attached cells in comparison to test group. 
That could be due to exposing some areas of previously contaminated titanium surfaces by 
mechanical debridement. However, there are still areas where smear layer was still present 
preventing further attachment of cells since mechanical debridement cannot cover the 
whole decontaminated surface.  The titanium surface in this group shows few cells and 
some deposits as well, which proves that mechanical debridement alone, is insufficient. 
The absence of air abrasion use and the application of citric acid followed by sterile saline 
could explain how the surface did not change entirely to a hydrophilic surface but merely 
a more deposit free surface. 
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7.2 Quantitative Analysis study of various elements: 
 
7.2.1 Effect of decontamination treatment on presence or absence of Deposits 
 
Analyzing our results shows that decontamination was significantly associated with lower 
odds for the presence of deposits on the surface of the implant. This is expected since the 
deposits are a proxy of the efficacy of the decontamination protocol. There were no 
deposits detected post-decontamination in all the samples which proves that the 
decontamination protocol works efficiently in removing, mechanically, all of the deposits. 
When we adjusted the analysis by implant or by being priory used (being test or control), 
did not change significantly the findings. This means that the effect of decontamination on 
deposits was more powerful than the potential effect of implant or prior use on deposits. 
Control groups showed absence of deposits before and after decontamination process, this 
adds internal validity to our analysis since it is expected not to find deposits on unused 
implants.  
 
7.2.2 Effect of decontamination treatment on Titanium percentage levels 
 
The titanium composition of implants before and after our decontamination method was 
different across the various implants (Figure 3). We noted a difference between test and 
control implants, more specifically, the titanium percentage did not change among control 
implants before and after decontamination protocol. In contrast, the test group had a higher 
titanium percentage after decontamination. This is likely due to the fact that the test group 
  107 
were used and therefore were covered with deposits that were masking the true titanium 
composition of implant and hence, after decontamination titanium is freshly exposed to 
new cellular attachment. Additionally, the fact that control implants retained the same 
titanium percentage before and after decontamination is a hint that the protocol does not 
alter the titanium percentage of the implants. In other words, since these implants were 
clean, we were able to accurately measure their true titanium composition. The consistency 
of our results before and after the decontamination in the control implants provides internal 
validity of our study since it proves that our measurements were performed without 
significant error. 
 
7.2.3 Effect of decontamination treatment on Oxygen percentage levels 
 
Similarly to the results of the titanium, the oxygen percentage of implants before and after 
our decontamination method is different across the various implants. Similarly to the 
titanium, the test implant behaved differently in comparison to control group. In other 
words, the percentage of oxygen in control group did not change with the decontamination 
protocol. In contrast, in test group, oxygen percentage decreased.  
This could have lots of explanations. One of them is that the deposits are mainly comprised 
of calculus and bacterial degradation products and consequently have high concentration 
of hydrocarbon molecules and hence atoms of carbon, oxygen and hydrogen. By removing 
the deposits, the decontamination protocol removed these molecules as well, which have a 
high concentration of oxygen, and exposed the surface of the implants. Another 
explanation would be that decontaminating the surface of test implants, might have lowered 
the high concentration of free oxygen, which means that it bonded to the titanium causing 
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titanium oxide (TiO2) to be formed. TiO2 is well known for enhancing cellular attachment 
109 since it increases hydrophilicity of the surface. No matter what the cause is, the fact that 
the control implants have the same oxygen composition before and after the 
decontamination protocol, adds internal validity in our study since it proves that we were 
able to measure the oxygen composition without significant error. It also shows that the 
decontamination protocol itself does not alter the oxygen composition of the implant. 
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8 Conclusion  
 
The results of this study showed that implants diagnosed with peri-implantitis and 
subsequently lost osseointegration with surrounding bone, will benefit from suggested 
decontamination technique. Osteoprogenitor cells showed higher attachment, proliferation 
and distribution over implant surfaces that were previously contaminated after 
decontamination protocol when compared to different control groups’ surfaces that did not 
receive the exact same protocol. 
Titanium percentages were statistically significantly higher on implant surfaces after 
decontaminating the surface of implants, which means that the protocol effectively 
removes smear layer that was previously covering titanium surfaces. Oxygen percentages 
were noticeably lower after decontamination though not statistically significant due to the 
presence of Oxygen as an element in the actual hydrocarbon contaminants of implant 
surface. The protocol also showed statistically significant effectiveness in cleaning the 
surface since no deposits were detected after decontamination.  
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9 Clinical Considerations 
 
 
From the light that this study shed on our clinical judgment, It is recommended that 
implants that are diagnosed with peri-implantitis and have lost bone support over few 
threads and with the patient’s desire along the clinician’s approval to keep the implant in 
the oral cavity versus explanting it, this protocol can prolong the life of these implants by 
decontaminating them using a surgical flap to ensure total access to failed implant surface. 
Adding bone grafts and other biological enhancements would add benefit to the protocol 
though it was not tested in this study. Prolonging the life of a previously diagnosed peri-
implantitis implant would benefit a lot of patients since it is economically a viable solution 
along with it being a less invasive solution when compared to total explantation of the 
implant.  
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